All News #Library
Biotech
Lumen Bio`s LMN-201: 100% Initial C. difficile Cure in RePreve Trial
03 Apr 2025 //
PR NEWSWIRE
Lumen Bioscience Awarded $8.8 million from U.S. Department of Defense
11 May 2023 //
PR NEWSWIRE

Market Place
Sourcing Support